TipRanks
Argonaut Resources (AU:ORP)
ASX:ORP
Want to see AU:ORP full AI Analyst Report?

Argonaut Resources (ORP) AI Stock Analysis

0 Followers

Top Page

AU:ORP

Argonaut Resources

(Sydney:ORP)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - Gpt-5.6Sol)
Rating:44Neutral
Price Target:
AU$0.08
â–¼(-40.71% Downside)
Action:Reiterated
Date:10/06/26
The score is weighed down primarily by a pre-revenue, loss-making and cash-burning financial profile, despite a low-debt balance sheet. Technical indicators also show weak momentum with the price below key moving averages and a negative MACD. Valuation offers limited support due to negative earnings and no dividend yield.
Positive Factors
Low Leverage
Very low leverage gives Argonaut greater financial flexibility while it develops its mineral exploration assets. The sharp debt reduction limits interest and refinancing pressure, allowing more of its capital base to support exploration and potential commercialization rather than debt servicing.
Negative Factors
Pre-Revenue Business
The absence of revenue shows that Argonaut has not yet reached commercial operating scale, leaving its financial profile dependent on exploration progress rather than established customer demand. Until revenue starts, the company cannot demonstrate recurring economics or self-funded growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage gives Argonaut greater financial flexibility while it develops its mineral exploration assets. The sharp debt reduction limits interest and refinancing pressure, allowing more of its capital base to support exploration and potential commercialization rather than debt servicing.
Read all positive factors

Argonaut Resources (ORP) vs. iShares MSCI Australia ETF (EWA)

Argonaut Resources Business Overview & Revenue Model

Company Description
Orpheus Uranium Limited is an Australian entity, based in Unley, that engages in the discovery and advancement of various mineral assets via its subsidiaries. Founded in 1985, the company primarily targets deposits of uranium, copper, gold, nickel...

Argonaut Resources Financial Statement Overview

Summary
High-risk, pre-revenue profile: no revenue in FY2025–FY2026 and profitability remains deeply negative despite losses narrowing. The balance sheet is a relative strength with very low debt and rising equity, but ongoing negative operating and free cash flow indicates continued cash burn and likely funding dependence unless commercialization occurs.
Income Statement
18
Very Negative
Balance Sheet
72
Positive
Cash Flow
33
Negative
BreakdownJun 2025Jun 2024
Income Statement
Total Revenue0.000.00
Gross Profit-77.17K-58.21K
EBITDA-2.11M-2.74M
Net Income-1.80M-2.81M
Balance Sheet
Total Assets10.74M7.67M
Cash, Cash Equivalents and Short-Term Investments4.98M4.18M
Total Debt21.59K81.78K
Total Liabilities782.51K234.19K
Stockholders Equity9.96M7.44M
Cash Flow
Free Cash Flow-1.99M-1.54M
Operating Cash Flow-1.89M-1.53M
Investing Cash Flow-1.44M-683.67K
Financing Cash Flow4.14M2.70M

Argonaut Resources Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.14
Price Trends
50DMA
0.12
Negative
100DMA
0.10
Negative
200DMA
0.08
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
31.33
Neutral
STOCH
7.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ORP, the sentiment is Negative. The current price of 0.14 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.12, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 31.33 is Neutral, neither overbought nor oversold. The STOCH value of 7.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ORP.

Argonaut Resources Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
47
Neutral
AU$16.68M-4.60-10.76%――49.10%
45
Neutral
AU$14.07M-14.00-8.30%――-40.00%
44
Neutral
AU$32.75M-16.21-21.42%――53.60%
44
Neutral
AU$33.09M-3.25-51.72%――-37.56%
43
Neutral
AU$18.04M-3.89-21.01%――93.65%
42
Neutral
AU$10.95M-2.37-83.24%――-9.30%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:ORP
Argonaut Resources
0.09
0.03
50.88%
AU:TSL
Titanium Sands
0.01
0.00
0.00%
AU:WIN
Widgie Nickel Limited
0.02
-0.02
-54.55%
AU:REE
RareX Limited
0.01
-0.03
-76.19%
AU:SGA
Sarytogan Graphite Limited
0.06
-0.08
-55.00%
AU:OD6
OD6 Metals Ltd.
0.09
0.02
27.14%

Argonaut Resources Corporate Events

Orpheus Uranium Secures Oobagooma Project, Strengthening Western Australian Portfolio
Oct 23, 2026
Orpheus Uranium has completed the acquisition of the Oobagooma Uranium Project in Western Australia’s Canning Basin, adding a significant asset to its uranium exploration portfolio. The transaction, undertaken with Elevate Uranium, includes ...
Orpheus Uranium Issues Shares to Acquire New Exploration Projects
Oct 23, 2026
Orpheus Uranium Limited has issued 22,500,000 fully paid ordinary shares as consideration for the acquisition of uranium exploration projects, underscoring its commitment to expanding its portfolio of early-stage assets in mining-friendly Australi...
Orpheus Uranium Seeks ASX Quotation for 20 Million New Shares
Oct 23, 2026
Orpheus Uranium Limited has lodged an application with the ASX for quotation of 20,000,000 ordinary fully paid shares, to be issued on October 23, 2026. The move expands the company’s listed capital base, potentially enhancing liquidity in i...
Orpheus Uranium Seeks ASX Quotation for Shares Linked to Marree Licence Acquisition
Oct 23, 2026
Orpheus Uranium Limited has applied for quotation of 2,500,000 new ordinary fully paid shares on the ASX. The securities are being issued in connection with the acquisition of exploration licences contiguous with and adjacent to the company’...
Orpheus Uranium advances drilling and expands district-scale tenure
Oct 22, 2026
During the quarter to 30 September 2026, Orpheus Uranium advanced its portfolio with a maiden drilling program at the Frome Project, following extensive geological work and permitting. The company also executed a strategic acquisition and lodged r...
Orpheus Uranium Boosts Cash Reserves With Equity Raising as Exploration Spend Climbs
Oct 22, 2026
Orpheus Uranium reported a cash outflow from operating activities of A$0.894 million for the quarter ended 30 September 2026, driven mainly by staff, administration and business development costs. With no receipts from customers and operating expe...
Orpheus Uranium Wins Strong Shareholder Backing at AGM
Oct 22, 2026
Shareholders of Orpheus Uranium Limited overwhelmingly endorsed all resolutions at the company’s annual general meeting on 22 October 2026, including adoption of the remuneration report and the re-election of director Simon Mitchell. Investo...
Orpheus Uranium Defines Key Redox Corridors at Frome Project
Oct 21, 2026
Orpheus Uranium has completed its first drilling program at the Erudina Uranium Prospect within the Frome Project in South Australia, targeting sandstone-hosted uranium in the Callabonna Sub-Basin. The campaign drilled 18 rotary mud holes for 3,60...
Orpheus Uranium outlines South Australian exploration strategy and risk framework
Oct 8, 2026
Orpheus Uranium Limited has released an investor presentation outlining its strategy to build a geologically relevant uranium exploration portfolio in South Australia. The document, prepared in October 2026, emphasises that it is informational in ...
Orpheus Uranium Calls 2026 AGM to Approve Capital and Governance Resolutions
Sep 21, 2026
Orpheus Uranium Limited has convened its 2026 Annual General Meeting for 22 October in Adelaide, specifying that shareholders must attend in person as no online participation will be available. The meeting will table the company’s annual rep...
Orpheus Uranium Details Cash Position and Asset Deals in Corporate Update
Sep 17, 2026
Orpheus Uranium has outlined its current corporate position in a September 2026 presentation, highlighting a cash balance of $4.96 million and liquid investments of $1.05 million, including 3.75 million shares in Prospect Resources. The company al...
Orpheus Uranium Releases 2025 Annual Report
Aug 31, 2026
Orpheus Uranium Limited has released its 2025 annual report, providing shareholders with a comprehensive overview of its financial performance and corporate governance for the year. The report includes audited financial statements, directors&#8217...
Orpheus Uranium details capital position and portfolio moves in new corporate presentation
Aug 25, 2026
Orpheus Uranium Limited, an ASX-listed uranium exploration company, is positioning itself within Australia’s energy resources sector, leveraging its technical team and strategic investments to advance uranium projects. The firm’s opera...
Orpheus Uranium expands Marree project with new exploration licences
Aug 18, 2026
Orpheus Uranium has secured three new exploration licences, EL 7144, EL 7145 and EL 7146, for its wholly owned subsidiary Trachre Pty Ltd, expanding the footprint and continuity of its Marree Uranium Project in South Australia. The licences form p...
Orpheus Uranium to Expand Marree Footprint with Strategic Tenement Deal
Aug 13, 2026
Orpheus Uranium has executed a sale agreement with Adavale Resources to acquire up to seven exploration licences covering about 2,513 square kilometres contiguous with its existing Marree Uranium Project in South Australia. The deal will materiall...
Adavale Sells Marree Uranium Assets to Refocus on Parkes Gold-Copper Project
Aug 13, 2026
Adavale Resources has executed a sale agreement with Orpheus Uranium for its Marree Embayment uranium portfolio, comprising seven granted exploration licences. The deal delivers $650,000 in cash and 5 million Orpheus shares, giving Adavale a 1.25%...
Orpheus Uranium expands capital base with new share issue to fund exploration
Aug 4, 2026
Orpheus Uranium Limited has issued 47,222,222 fully paid ordinary shares at $0.09 per share, expanding its share capital through a placement conducted without a prospectus under Section 708A of the Corporations Act. The company confirmed ongoing c...
Orpheus Uranium Plans New Option Issue to Support Capital Needs
Jul 29, 2026
Orpheus Uranium Limited has notified the ASX of a proposed issue of new options as part of a placement or other capital-raising initiative. The securities will be listed under a new class code and represent derivative instruments tied to the compa...
Orpheus Uranium Plans Major Share Placement to Bolster Capital Base
Jul 29, 2026
Orpheus Uranium Limited has notified the ASX of a proposed placement of up to 47,222,222 ordinary fully paid shares, seeking quotation for the new securities in line with the exchange’s listing rules. The proposed issue, scheduled for 4 Augu...
Orpheus Uranium Secures $4.25m to Fast-Track Drilling Across Australian Projects
Jul 29, 2026
Orpheus Uranium has secured firm commitments for a $4.25 million share placement at $0.09 per share, issuing approximately 47.2 million new shares to sophisticated, institutional and professional investors. The placement was supported by existing ...
Orpheus Uranium advances drilling plans as nuclear demand outlook strengthens
Jul 23, 2026
Orpheus Uranium used its latest quarterly update to highlight growing global demand for reliable baseload power, particularly nuclear energy, as data centres place increasing strain on energy systems, and noted that shifting policy attitudes in Au...
Orpheus Uranium Posts Modest Quarterly Cash Burn, Ends June With A$5.1m in Cash
Jul 23, 2026
Orpheus Uranium reported a quarterly cash outflow from operations of A$422,000, driven mainly by staff and corporate administration costs, partially offset by interest income. Over the full year, operating cash burn reached A$1.64 million, highlig...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 06, 2026